CIK 0001815442 · Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812992166
- Phone
- 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,158,214
- in 2 filings, $3.4M under 10b5-1 plans
Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-22 | Booth Bruce Director | Sale 10b5-1 | −12 | $90.08 | $1K | 674,944 |
| 2026-04-22 | Booth Bruce Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,641 | 0 | ||
| 2026-04-22 | Booth Bruce Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −259 | 39,868 | ||
| 2026-04-22 | Chadwick Jeremy G Chief Operating Officer | Option exercise 10b5-1 | +100 | $30.17 | $3K | 61,302 |
| 2026-04-22 | Chadwick Jeremy G Chief Operating Officer | Option exercise 10b5-1 | +200 | $43.50 | $9K | 61,502 |
| 2026-04-22 | Chadwick Jeremy G Chief Operating Officer | Sale 10b5-1 | −300 | $90.00 | $27K | 61,202 |
| 2026-04-22 | Chadwick Jeremy G Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −100 | 45,434 | ||
| 2026-04-22 | Chadwick Jeremy G Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −200 | 58,263 | ||
| 2026-04-15 | Booth Bruce Director | Option exercise 10b5-1 | +2,200 | $14.18 | $31K | 2,200 |
| 2026-04-15 | Booth Bruce Director | Sale 10b5-1 | −2,200 | $89.95 | $198K | 0 |
| 2026-04-15 | Booth Bruce Director | Sale 10b5-1 | −2,750 | $90.10 | $248K | 3,899,917 |
| 2026-04-15 | Booth Bruce Director | Sale 10b5-1 | −385 | $90.10 | $35K | 674,956 |
| 2026-04-15 | Booth Bruce Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,200 | 5,641 | ||
| 2026-04-15 | Chadwick Jeremy G Chief Operating Officer | Option exercise 10b5-1 | +1,300 | $43.50 | $57K | 62,502 |
| 2026-04-15 | Chadwick Jeremy G Chief Operating Officer | Sale 10b5-1 | −1,300 | $90.00 | $117K | 61,202 |
| 2026-04-15 | Chadwick Jeremy G Chief Operating Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,300 | 58,463 | ||
| 2026-04-14 | Booth Bruce Director | Option exercise 10b5-1 | +4,159 | $14.18 | $59K | 4,159 |
| 2026-04-14 | Booth Bruce Director | Sale 10b5-1 | −4,159 | $89.97 | $374K | 0 |
| 2026-04-14 | Booth Bruce Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −4,159 | 7,841 | ||
| 2026-04-14 | Goodman Noah Chief Business Officer | Sale 10b5-1 | −1,347 | $90.00 | $121K | 50,195.44 |
Page 12 of 25 · 493 trades